hr19042
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2021 (NCT04887532)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06922305 | Phase 1 | Dec 27, 2023 | Hengrui Therapeutics, Inc. |
| NCT05476900 | Phase 2 | Aug 30, 2022 | Hengrui Therapeutics, Inc. |
| NCT05016323 | Phase 2 | Sep 9, 2021 | Hengrui Therapeutics, Inc. |
| NCT04887532 | Phase 1 | Jul 1, 2021 | Hengrui Therapeutics, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 4 | 4 | 2 | 2021 |
1 organizations
Page 1 / 1